Netherton syndrome
Clinical trials for Netherton syndrome explained in plain language.
Never miss a new study
Get alerted when new Netherton syndrome trials appear
Sign up with your email to follow new studies for Netherton syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a skin lotion tame the symptoms of a rare genetic disease?
Disease control Recruiting nowThis trial tests whether QRX003, a lotion applied to the skin, can reduce the redness, scaling, and itch caused by Netherton syndrome, a rare genetic condition. Participants apply the lotion twice daily for 3 months and visit the clinic every 4 to 6 weeks for checkups. The study …
Matched conditions: NETHERTON SYNDROME
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a lotion calm the severe skin symptoms of netherton syndrome?
Disease control Recruiting nowThis trial tests whether QRX003 lotion, applied to the skin, can safely reduce the severity of Netherton syndrome, a rare genetic condition causing red, scaly skin and intense itching. Researchers will enroll about 20 people aged 14 and older who have the condition. Participants …
Matched conditions: NETHERTON SYNDROME
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug trial hopes to tame rare skin disease
Disease control Recruiting nowThis early-stage trial tests a new drug called BCX17725 in healthy volunteers and people with Netherton syndrome, a rare genetic skin condition. The study aims to check safety, how the drug moves through the body, and whether it can reduce skin redness and scaling. About 78 parti…
Matched conditions: NETHERTON SYNDROME
Phase 1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New lotion shows promise for rare skin disorder
Disease control Recruiting nowThis study tests a lotion called QRX003 in people with Netherton Syndrome, a rare genetic skin condition. About 16 participants aged 4 and older will apply the lotion twice daily for 12 weeks. Researchers will check if it improves skin appearance and reduces itching.
Matched conditions: NETHERTON SYNDROME
Phase 2/3 • Sponsor: Quoin Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Microbiome study seeks clues in rare skin condition
Knowledge-focused Recruiting nowThis study looks at the bacteria, fungi, and viruses living on the skin, in the gut, and in the mouth of people with Netherton syndrome, a rare condition that damages the skin barrier and often causes allergies. Researchers will compare these microbes to those of healthy voluntee…
Matched conditions: NETHERTON SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC